← back to search

Jef Verbeek

Kosin University · BE
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Liver Disease and Transplantation, and Protease and Inhibitor Mechanisms.
h-index
21
citations
1,776
works
126
NIH funding
primary concept
Medicine
email

Recent publications

Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis
Gut 2025cited by 8position: middledoi
Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma
Drug Resistance Updates 2024cited by 22position: middledoi
Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure
Hepatology 2024cited by 20position: middledoi
Model-Informed Precision Dosing of Tacrolimus: A Systematic Review of Population Pharmacokinetic Models and a Benchmark Study of Software Tools
Clinical Pharmacokinetics 2024cited by 12position: middledoi
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH
Journal of Hepatology 2023cited by 38position: middledoi
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency
Gut 2021cited by 76position: middledoi
Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients
Intensive Care Medicine 2021cited by 40position: middledoi
Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
Liver International 2020cited by 136position: middledoi
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers
Gastroenterology 2020cited by 97position: middledoi
Diagnostic Accuracy of Biomarkers of Alcohol Use in Patients With Liver Disease: A Systematic Review
Alcoholism Clinical and Experimental Research 2020cited by 51position: lastdoi
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
BMJ Open Gastroenterology 2020cited by 40position: middledoi
An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present
Current Protocols in Mouse Biology 2016cited by 49position: middledoi
Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle
Cell Metabolism 2014cited by 252position: middledoi
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis
Gut 2014cited by 76position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Frederik Nevens · European Union3 papers (2014–2020)Johan Auwerx · Swiss Integrative Center for Human Health3 papers (2014–2024)Dongryeol Ryu · Salk Institute for Biological Studies2 papers (2014–2024)Pan Xu · Nantong University2 papers (2020–2024)Ad Masclee · Clinical Trial Center Maastricht2 papers (2020–2020)Eija Pirinen · University of Helsinki2 papers (2014–2014)David Cassiman · KU Leuven2 papers (2014–2016)Kristina Schoonjans · University of Lausanne2 papers (2014–2024) · 1 papers (2024–2024)Steven W.M. Olde Damink · Maastricht University1 papers (2020–2020) · 1 papers (2024–2024) · 1 papers (2020–2020) · 1 papers (2024–2024) · 1 papers (2020–2020)Otto M. van Delden · Amsterdam University Medical Centers1 papers (2020–2020)Massimo Zeviani · University of Padua1 papers (2014–2014)Yunju Jo · Salk Institute for Biological Studies1 papers (2024–2024)Dirk Kuypers · Utrecht University1 papers (2024–2024) · 1 papers (2020–2020)Young Suk Jo · Huntsman Cancer Institute1 papers (2014–2014)